User profiles for Y. Gasche
Yvan GascheFaculté de Médecine de Genève et Hirslanden Clinique des Grangettes Verified email at hirslanden.ch Cited by 11709 |
[HTML][HTML] Targeted temperature management at 33 C versus 36 C after cardiac arrest
Background Unconscious survivors of out-of-hospital cardiac arrest have a high risk of death
or poor neurologic function. Therapeutic hypothermia is recommended by international …
or poor neurologic function. Therapeutic hypothermia is recommended by international …
[HTML][HTML] Codeine intoxication associated with ultrarapid CYP2D6 metabolism
<p id="p001">Life-threatening opioid intoxication developed in a patient after he was given
small doses of codeine for the treatment of a cough associated with bilateral pneumonia. …
small doses of codeine for the treatment of a cough associated with bilateral pneumonia. …
[PDF][PDF] Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain
Y Gasche, PM Soccal, M Kanemitsu… - Front …, 2006 - access.archive-ouverte.unige.ch
… GF Hamann, Y. Okada & GJ Del Zoppo: Hemorrhagic transformation and microvascular
integrity during focal cerebral ischemi/reperfusion. J Cereb Blood Flow Metab 16(6), 1373-1378 (…
integrity during focal cerebral ischemi/reperfusion. J Cereb Blood Flow Metab 16(6), 1373-1378 (…
Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood—brain barrier dysfunction
Y Gasche, M Fujimura… - Journal of Cerebral …, 1999 - journals.sagepub.com
… Yvan Gasche … Y. Gasche is a research fellow supported by the Geneva University
Hospital Fund. PH Chan is a recipient of the Jacob Javits Neuroscience Investigator Award. …
Hospital Fund. PH Chan is a recipient of the Jacob Javits Neuroscience Investigator Award. …
Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia
Results of recent studies reveal vascular and neuroprotective effects of matrix metalloproteinase-9
(MMP-9) inhibition and MMP-9 gene deletion in experimental stroke. However, the …
(MMP-9) inhibition and MMP-9 gene deletion in experimental stroke. However, the …
Early appearance of activated matrix metalloproteinase-9 and blood–brain barrier disruption in mice after focal cerebral ischemia and reperfusion
Blood–brain barrier (BBB) disruption is thought to play a critical role in the pathophysiology
of ischemia/reperfusion. Matrix metalloproteinases (MMPs) are a family of proteolytic …
of ischemia/reperfusion. Matrix metalloproteinases (MMPs) are a family of proteolytic …
Matrix metalloproteinase inhibition prevents oxidative stress-associated blood–brain barrier disruption after transient focal cerebral ischemia
Oxidative stress generated during stroke is a critical event leading to blood–brain barrier (BBB)
disruption with secondary vasogenic edema and hemorrhagic transformation of infarcted …
disruption with secondary vasogenic edema and hemorrhagic transformation of infarcted …
Neuron-specific enolase as a predictor of death or poor neurological outcome after out-of-hospital cardiac arrest and targeted temperature management at 33 C and …
Background : Neuron-specific enolase (NSE) is a widely-used biomarker for prognostication
of neurological outcome after cardiac arrest, but the relevance of recommended cutoff …
of neurological outcome after cardiac arrest, but the relevance of recommended cutoff …
Standardized EEG interpretation accurately predicts prognosis after cardiac arrest
… Y. Gasche reports no disclosures. C. Hassager receives grant support from the Interreg IVA
ØKS program; honorarium for lectures from AstraZeneca, Teva, Novartis, and ViCare Medical…
ØKS program; honorarium for lectures from AstraZeneca, Teva, Novartis, and ViCare Medical…
Overexpression of copper/zinc superoxide dismutase in transgenic rats protects vulnerable neurons against ischemic damage by blocking the mitochondrial pathway …
Mitochondria are known to be involved in the early stage of apoptosis by releasing cytochrome
c, caspase-9, and the second mitochondria-derived activator of caspases (Smac). We …
c, caspase-9, and the second mitochondria-derived activator of caspases (Smac). We …